期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Lipocalin-2 as a biomarker for diabetic nephropathy
1
作者 Kiran Dahiya praveen prashant +3 位作者 Rakesh Dhankhar Kumud Dhankhar Sushil Kumar Sonia Vashist 《World Journal of Meta-Analysis》 2023年第4期92-101,共10页
Diabetes is a major global public health issue.The prevalence of type 1 diabetes is comparatively static,as hereditary and genetic causes are involved,while type 2 diabetes(T2D)prevalence is increasing day by day.T2D ... Diabetes is a major global public health issue.The prevalence of type 1 diabetes is comparatively static,as hereditary and genetic causes are involved,while type 2 diabetes(T2D)prevalence is increasing day by day.T2D is associated with chronic complications,including diabetic neuropathy(DN),nephropathy,retinopathy,and other complications like diabetic foot.DN is the main complication of both types of diabetes.DN can be diagnosed by routine laboratory tests,microalbuminuria>300 mg/24 h,and a gradual decrease in glomerular filtration rate.As the appearance of microalbuminuria is a late manifestation,an early marker for renal damage is needed.Lipocalin-2,also known as neutrophil gelatinaseassociated lipocalin(NGAL),is a small protein purified from neutrophil granules and a good marker for kidney disease.NGAL is a transporter protein responsible for many physiological processes,such as inflammation,generation of the immune response,and metabolic homeostasis.NGAL has been reported to depict the early changes in renal damage when urine microalbumin is still undetecable.Therefore,elucidating the role of NGAL in detecting DN and understanding its mechanism can help establish it as a potential early marker for DN. 展开更多
关键词 Type 1 diabetes Type 2 diabetes Diabetic nephropathy Lipocalin-2 Early biomarkers for kidney disease Acute kidney injury
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部